NVO
Novo Nordisk A/S
NYSE · Healthcare · Drug Manufacturers - General · DK
$46.60
−1.92%Margins
Gross margin
80.6%
EBITDA margin
54.9%
EBIT margin
43.1%
Net margin
35.3%
FCF margin
14.8%
52.6%
Return on equity
19.6%
Return on assets
39.3%
Return on invested capital
0.57x
Asset turnover
$20.7B
Cash from operations
$1.57
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026